SE7610501L - Nya n-aryl-n(1-l-4-piperidinyl)-arylacetamider - Google Patents

Nya n-aryl-n(1-l-4-piperidinyl)-arylacetamider

Info

Publication number
SE7610501L
SE7610501L SE7610501A SE7610501A SE7610501L SE 7610501 L SE7610501 L SE 7610501L SE 7610501 A SE7610501 A SE 7610501A SE 7610501 A SE7610501 A SE 7610501A SE 7610501 L SE7610501 L SE 7610501L
Authority
SE
Sweden
Prior art keywords
arylacetamides
piperidinyl
aryl
new
formula
Prior art date
Application number
SE7610501A
Other languages
English (en)
Other versions
SE427839B (sv
Inventor
S Sanczuk
H K F Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SE7610501L publication Critical patent/SE7610501L/sv
Publication of SE427839B publication Critical patent/SE427839B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7610501A 1975-09-23 1976-09-22 Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider SE427839B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (2)

Publication Number Publication Date
SE7610501L true SE7610501L (sv) 1977-03-24
SE427839B SE427839B (sv) 1983-05-09

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7610501A SE427839B (sv) 1975-09-23 1976-09-22 Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider

Country Status (29)

Country Link
JP (1) JPS6016417B2 (sv)
AT (1) AT363935B (sv)
AU (1) AU510029B2 (sv)
BG (1) BG27543A3 (sv)
CA (1) CA1068271A (sv)
CH (1) CH628623A5 (sv)
CS (1) CS222663B2 (sv)
DE (1) DE2642856A1 (sv)
DK (1) DK150478C (sv)
ES (1) ES451768A1 (sv)
FI (1) FI61482C (sv)
FR (1) FR2325377A1 (sv)
GB (1) GB1539473A (sv)
GR (1) GR58469B (sv)
HU (1) HU172964B (sv)
IE (1) IE43802B1 (sv)
IL (1) IL50522A (sv)
IT (1) IT1073893B (sv)
LU (1) LU75837A1 (sv)
NL (1) NL187267C (sv)
NO (1) NO147672C (sv)
NZ (1) NZ181972A (sv)
PH (1) PH12497A (sv)
PL (2) PL192578A1 (sv)
PT (1) PT65631B (sv)
RO (1) RO70079A (sv)
SE (1) SE427839B (sv)
SU (1) SU747424A3 (sv)
YU (1) YU39973B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
RU2489431C2 (ru) 2007-04-23 2013-08-10 Янссен Фармацевтика Н.В. Тиа(диа)золы как быстро диссоциирующие антагонисты рецептора допамина 2
JP5431305B2 (ja) 2007-04-23 2014-03-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 高速解離性ドパミン2受容体アンタゴニストとしての4−アルコキシピリダジン誘導体
AU2008240727C1 (en) * 2007-04-23 2013-10-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
JP5417439B2 (ja) 2008-07-03 2014-02-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 5−ht6受容体アンタゴニストとしての置換された6−(1−ピペラジニル)−ピリダジン類
EA019048B1 (ru) 2008-07-31 2013-12-30 Янссен Фармацевтика Нв Пиперазин-1-илтрифторметилзамещенные пиридины в качестве быстро диссоциирующихся антагонистов d-рецепторов дофамина
CN118496638B (zh) * 2024-07-22 2024-11-22 海安浩驰科技有限公司 一种抗紫外车窗膜及其制备方法

Also Published As

Publication number Publication date
FR2325377B1 (sv) 1980-04-18
NL7610513A (nl) 1977-03-25
FI61482B (fi) 1982-04-30
IL50522A (en) 1979-09-30
GR58469B (en) 1977-10-14
CS222663B2 (en) 1983-07-29
NL187267B (nl) 1991-03-01
GB1539473A (en) 1979-01-31
DK150478B (da) 1987-03-09
SE427839B (sv) 1983-05-09
FI61482C (fi) 1982-08-10
FR2325377A1 (fr) 1977-04-22
PL192578A1 (pl) 1979-02-26
NL187267C (nl) 1991-08-01
AT363935B (de) 1981-09-10
JPS6016417B2 (ja) 1985-04-25
AU510029B2 (en) 1980-06-05
CH628623A5 (en) 1982-03-15
ES451768A1 (es) 1978-05-01
DK427876A (da) 1977-03-24
IL50522A0 (en) 1976-11-30
PT65631B (en) 1978-07-05
NO147672B (no) 1983-02-14
JPS5239683A (en) 1977-03-28
HU172964B (hu) 1979-01-28
PT65631A (en) 1976-10-01
IE43802L (en) 1977-03-23
YU233676A (en) 1983-01-21
RO70079A (ro) 1982-10-26
NO147672C (no) 1983-05-25
FI762698A7 (sv) 1977-03-24
DK150478C (da) 1987-10-05
ATA702976A (de) 1981-02-15
LU75837A1 (sv) 1977-05-04
IT1073893B (it) 1985-04-17
AU1787876A (en) 1978-03-23
DE2642856C2 (sv) 1990-06-21
IE43802B1 (en) 1981-06-03
PH12497A (en) 1979-04-05
YU39973B (en) 1985-06-30
NZ181972A (en) 1978-07-28
PL117323B1 (en) 1981-07-31
BG27543A3 (bg) 1979-11-12
CA1068271A (en) 1979-12-18
NO763054L (no) 1977-03-24
SU747424A3 (ru) 1980-07-23
DE2642856A1 (de) 1977-03-24

Similar Documents

Publication Publication Date Title
DK136714B (da) Analogifremgangsmåde til fremstilling af substituerede piperidinderivater eller syreadditionssalte deraf.
SE7604052L (sv) Nya erytromycinderivat och forfarande for framstellning derav
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE7703842L (sv) Nya piperazin- och piperinderivat
NL180587C (nl) Werkwijze voor het bereiden van 1-((4,4-diarylbutyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-onen, en werkwijze voor het bereiden of vervaardigen van deze verbindingen bevattende farmaceutische preparaten.
SE7608265L (sv) 1-(bensazolylalkyl)-piperidiner
SE7611137L (sv) 1-bensazolylalkyl-4-substituerade piperidiner
GB1539473A (en) N-aryl-n-(1-l-4-piperidinyl)-arylacetamides
SE7714374L (sv) 1,4-dihydropyridinforbindelser
SE7514271L (sv) Sett att framstella nya 1,3-disubstituerade propanol-(2)-derivat
SE7604476L (sv) Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar
GB1492528A (en) Pyrazinyl piperazine derivatives
SE424553B (sv) Forfarande for framstellning av nya indazol-derivat
SE7701187L (sv) Nya piperazinderivat och sett att framstella desamma
SE7811455L (sv) 2-imino-imidazolidin-derivat
GB1471847A (en) Dibenzofuran derivatives
ES414955A1 (es) Procedimiento para la preparacion de 4-(4-bifenilil)-buta- noles.
SU674671A3 (ru) Способ получени производных пирролидина
GR33644B (el) Μεθοδος δια την παρασκευην νεων αλογονουποκατεστημενων τετραυδρο-κιναζολινων.
SE7508793L (sv) Antibiotiska derivat av xk-62-2 samt forfarande for framstellning derav
SE410314B (sv) Forfarande for framstellning av nya derivat av n-(p-bensamid)-2-pyrrolidon-4-karbonsyra med verdefulla antiulceregenskaper
SE7701845L (sv) Forfarande for framstellning av l-sulfonyl-5(6)-substituerade bensimidazoler
ES398080A1 (es) Procedimiento para la preparacion de derivados de 1-vinil- carbonil-piperazina.
SE7506729L (sv) Forfarande for framstellning av nya substituerade 1-(2',4',6'-trihydrofenyl)-propandion-(1,2)-foreningar
SE412907B (sv) Forfarande for framstellning av nya n-2'-karboxifenyl-4-klorantranilsyror

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7610501-4

Effective date: 19910409

Format of ref document f/p: F